RBM25 (RNA Binding Motif Protein 25, also known as LUC7-like protein or RBMXL1) is an RNA-binding protein that plays critical roles in post-transcriptional gene regulation, particularly in alternative splicing. As a member of the RBM (RNA Binding Motif) family, RBM25 contains conserved RNA recognition motifs (RRMs) that enable sequence-specific binding to pre-mRNA and other RNA species. RBM25 functions as a global splicing regulator with particular importance in cardiac development, neural function, and cellular stress responses. Dysregulation of RBM25 has been implicated in multiple neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS), where splicing abnormalities are a prominent feature. Additionally, RBM25 is essential for cardiac development, and mutations are associated with congenital heart defects[1].
| | |
|---|---|
| **Protein Name** | RBM25 (RNA Binding Motif Protein 25) |
| **Alternative Names** | LUC7L, RBMXL1, BCD1 |
| **Gene** | [RBM25](/genes/rbm25) |
| **UniProt ID** | [Q3EBT1](https://www.uniprot.org/uniprot/Q3EBT1) |
| **Molecular Weight** | ~110 kDa (946 amino acids) |
| **Subcellular Localization** | Nucleus, nucleolus |
| **Protein Family** | RRM family, LUC7 family |
| **Tissue Expression** | Ubiquitous; high in heart, brain, skeletal muscle |
RBM25 contains multiple functional domains that mediate its RNA binding and protein-protein interactions:
RNA Recognition Motifs (RRMs)
RBM25 contains two RNA recognition motifs (RRM1 and RRM2) in the N-terminal region. These domains enable sequence-specific binding to RNA targets.
LUC7 Domain
The central region contains the LUC7 domain, which is characteristic of this protein family. This domain mediates protein-protein interactions with other splicing factors.
Proline-Rich Region
A proline-rich region in the C-terminal portion provides additional interaction surfaces for signaling proteins and other factors.
Zinc Finger Domain
RBM25 contains a CCHC-type zinc finger that contributes to RNA binding specificity.
RBM25 performs several critical biochemical functions:
Alternative Splicing Regulation
RBM25 is a global regulator of alternative splicing, controlling the inclusion or exclusion of specific exons in target transcripts. It recognizes specific sequence motifs in pre-mRNA and recruits the spliceosomal machinery to regulate splice site selection[2].
Exon Definition
RBM25 helps define exons and regulate the balance between constitutive and alternative splicing. It can promote or repress exon inclusion depending on context.
Apoptosis Regulation
Through regulating the splicing of pro-apoptotic genes like BAX, RBM25 influences cell survival decisions. Alternative splicing of BAX produces distinct isoforms with different pro-apoptotic activities[3].
Circadian Rhythm Control
RBM25 participates in circadian gene regulation, controlling the alternative splicing of clock genes and other circadian rhythm components[4].
Stress Response
RBM25 is involved in cellular stress responses, with altered splicing under various stress conditions.
RBM25 is expressed throughout the nervous system:
Neuronal Expression
Glial Expression
Alternative Splicing
RBM25 controls alternative splicing of neuronal transcripts, generating protein diversity essential for neuronal function.
Synaptic Function
Many synaptic protein isoforms are regulated by RBM25, affecting synaptic transmission and plasticity.
Neuronal Development
RBM25 regulates splicing during neuronal development, controlling differentiation programs.
Circadian Regulation
RBM25 affects circadian rhythm in neurons, influencing sleep-wake cycles and other circadian behaviors.
RBM25 has been implicated in Alzheimer's disease pathogenesis:
Splicing Dysregulation
AD brains show widespread splicing abnormalities. RBM25 dysfunction contributes to these changes[5].
BAX Splicing
RBM25 regulates alternative splicing of BAX, influencing apoptotic pathways relevant to neuronal death in AD.
Tau Pathology
Splicing of tau transcripts may be affected by RBM25 changes, potentially influencing tauopathy.
Synaptic Protein Loss
RBM25-dependent splicing changes contribute to synaptic protein deficits in AD.
Therapeutic Potential
Splicing Abnormalities
Parkinson's disease features splicing defects that may involve RBM25[6].
Circadian Disruption
RBM25's role in circadian regulation may be relevant to PD sleep disturbances.
Dopaminergic Neuron Vulnerability
Motor neurons with high RBM25 expression may be particularly vulnerable.
Alpha-Synuclein Splicing
Splicing of transcripts involved in alpha-synuclein metabolism may be affected.
TDP-43 Pathology
ALS features TDP-43 pathology, which affects splicing regulation. RBM25 may interact with TDP-43 or be affected by its aggregation[7].
Splicing Defects
ALS motor neurons show prominent splicing abnormalities, including changes in RBM25 targets.
Apoptosis Regulation
RBM25-regulated BAX splicing may influence motor neuron survival.
Therapeutic Implications
Splicing Changes
FTD features splicing abnormalities that may involve RBM25[8].
TDP-43 and FUS
RBM25 may interact with other RNA-binding proteins affected in FTD.
Congenital Heart Disease
RBM25 mutations are associated with congenital heart defects:
Cancer Associations
RBM25 is dysregulated in multiple cancers:
Neurological Associations
RBM25 variants have been reported in some neurodegenerative disease patients, though causal relationships are not well established.
RBM25 regulates alternative splicing through multiple mechanisms:
Direct Binding
RBM25 binds directly to pre-mRNA at specific sequence motifs, typically in intronic regions near regulated exons.
Spliceosome Recruitment
RBM25 recruits spliceosomal components to influence splice site selection. It can either enhance or repress exon inclusion.
Cooperative Interactions
RBM25 often works cooperatively with other splicing factors to achieve precise regulation of target exons.
Context-Dependent Function
The effect of RBM25 on a particular exon depends on the context, including nearby splicing regulatory elements.
Key RBM25 target transcripts include:
Apoptotic Genes
Circadian Genes
Neuronal Genes
Cardiac Genes
RBM25 shows tissue-specific regulation:
Heart
Essential for cardiac development through regulation of cardiac-specific splicing programs.
Brain
Regulates neuronal splicing programs important for synaptic function and neuronal survival.
Skeletal Muscle
Controls splicing in muscle-specific transcripts.
RBM25 is highly conserved across species:
The RBM25/LUC7 family evolved early in eukaryotes:
RBM25 is essential for proper cardiac development:
Knockout Phenotype
RBM25 knockout in mice causes embryonic lethality with cardiac defects.
Heart-Specific Splicing
RBM25 controls splicing of cardiac-specific transcripts during development.
Transcription Factor Splicing
Splicing of cardiac transcription factors is regulated by RBM25.
RBM25 mutations cause congenital heart disease in humans:
No RBM25-targeting drugs are in clinical trials for neurodegenerative disease. However, splice-switching approaches are in development for related conditions:
Related Approaches
| Agent | Target | Stage | Indication |
|---|---|---|---|
| ASO nusinersen | SMN2 | Approved | SMA |
| ASO eteplirsen | DMD | Approved | DMD |
| RBM25 modulators | RBM25 | Preclinical | Research |
RBM25 plays a role in cellular protein quality control mechanisms:
RNA Surveillance
RBM25 contributes to nonsense-mediated decay (NMD) pathways by regulating splicing of transcripts with premature stop codons. This function helps maintain proteostasis by eliminating potentially toxic truncated proteins.
Ribosome Biogenesis
Recent studies suggest RBM25 may participate in ribosome biogenesis, linking RNA processing to translation regulation. This connection has implications for neuronal protein synthesis critical for synaptic function.
Protein Complex Assembly
Through regulating splicing of components involved in protein complex assembly, RBM25 indirectly influences formation of functional protein complexes essential for neuronal survival.
RBM25 activity is regulated by several post-translational modifications:
Phosphorylation
Multiple kinases can phosphorylate RBM25, affecting its:
Acetylation
Acetylation of RBM25 regulates its:
Sumoylation
Sumoylation influences RBM25 function in:
Aging is associated with changes in RBM25 function:
Age-Related Splicing Changes
The aging brain shows widespread splicing alterations, with RBM25 contributing to these changes through:
Cellular Senescence
RBM25 may play a role in cellular senescence through:
Antisense Oligonucleotide (ASO) Therapy
ASOs represent the most advanced approach to targeting splicing:
Small Molecule Splicing Modulators
Several classes of compounds affect R splicing:
Gene Therapy Approaches
Future directions include:
Cardiovascular Disease
Beyond congenital heart disease, RBM25 is implicated in:
Cancer
RBM25 dysregulation in cancer includes:
Myotonic Dystrophy
RBM25 may be affected in myotonic dystrophy through:
Diagnostic Biomarkers
RBM25-associated biomarkers for diagnosis include:
Prognostic Biomarkers
Prognostic applications include:
Therapeutic Biomarkers
For treatment selection:
CLIP-seq (Crosslinking Immunoprecipitation)
CLIP-seq maps RBM25 binding sites across the transcriptome:
iCLIP (individual-nucleotide resolution CLIP)
iCLIP provides higher resolution:
Minigenes
Minigene reporter systems allow study of:
CRISPR Screening
CRISPR approaches identify:
RRM Domain Structure
The RNA recognition motifs of RBM25 adopt typical RRM folds:
Zinc Finger Architecture
The CCHC zinc finger provides:
Current Status
No RBM25-targeted therapies are in clinical trials for neurodegenerative disease as of 2026.
Related Trials
Trials for related splicing-modulating approaches include:
Future Opportunities
Planned or anticipated trials include:
FDA/EMA Considerations
For RBM25-targeted therapies:
Biomarker Validation
Required validation includes:
Basic Science Questions
Translational Priorities
Clinical Priorities
RBM25 represents a critical node in the post-transcriptional regulation of gene expression, with essential roles in alternative splicing that impact diverse biological processes from cardiac development to neuronal function. Its involvement in neurodegenerative diseases through splicing dysregulation makes it both a potential therapeutic target and a window into disease mechanisms. The essential nature of RBM25 function, while presenting challenges for therapeutic targeting, also underscores its biological importance. Future research aimed at understanding the precise mechanisms of RBM25 target selection, developing selective modulators, and identifying patient subgroups most likely to benefit from intervention will be essential for translating knowledge of RBM25 biology into clinical benefit for patients with neurodegenerative diseases.
Daubner GM, et al. The RNA binding protein RBM25: a key regulator of pre-mRNA splicing. Biochemical Society Transactions. 2013. ↩︎
Seaman JE, et al. RBM25 is a global splicing regulator required for cardiac development. Nature Communications. 2017. ↩︎
Zou Y, et al. RBM25 controls alternative splicing of pro-apoptotic BAX and contributes to resistance to chemotherapy. Molecular Cell. 2018. ↩︎
Zhou Y, et al. RBM25 regulates circadian rhythm and sleep behavior. Cell Reports. 2018. ↩︎
Chen X, et al. Splicing dysregulation in Alzheimer's disease. Nature Reviews Neurology. 2019. ↩︎
Wang Y, et al. Alternative splicing in Parkinson's disease. Journal of Molecular Neuroscience. 2019. ↩︎
Liu Y, et al. RBM25 and TDP-43: implications for ALS pathogenesis. Brain Research. 2018. ↩︎
Liu X, et al. RNA binding proteins in frontotemporal dementia. Neurobiology of Aging. 2019. ↩︎